🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
11.75
-0.23 (-1.92%)
Nov 20, 2026, 4:00 PM EST - Market closed

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of $122.25 million. The enterprise value is -$29.59 million.

Market Cap122.25M
Enterprise Value -29.59M

Important Dates

The last earnings date was Monday, October 26, 2026, before market open.

Earnings Date Oct 26, 2026
Ex-Dividend Date n/a

Share Statistics

Medifast has 10.40 million shares outstanding. The number of shares has increased by 0.94% in one year.

Current Share Class 10.40M
Shares Outstanding 10.40M
Shares Change (YoY) +0.94%
Shares Change (QoQ) +0.41%
Owned by Insiders (%) 3.59%
Owned by Institutions (%) 59.62%
Float 8.44M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.41
Forward PS 0.44
PB Ratio 0.68
P/TBV Ratio 0.68
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.82, with a Debt / Equity ratio of 0.11.

Current Ratio 4.82
Quick Ratio 4.12
Debt / Equity 0.11
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -20.69% and return on invested capital (ROIC) is -84.22%.

Return on Equity (ROE) -20.69%
Return on Assets (ROA) -8.56%
Return on Invested Capital (ROIC) -84.22%
Return on Capital Employed (ROCE) -17.58%
Weighted Average Cost of Capital (WACC) 6.87%
Revenue Per Employee $788,347
Profits Per Employee -$107,505
Employee Count380
Asset Turnover 1.18
Inventory Turnover 4.15

Taxes

In the past 12 months, Medifast has paid $11.70 million in taxes.

Income Tax 11.70M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +9.10% in the last 52 weeks. The beta is 0.69, so Medifast's price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change +9.10%
50-Day Moving Average 12.12
200-Day Moving Average 11.40
Relative Strength Index (RSI) 39.46
Average Volume (20 Days) 139,146

Short Selling Information

The latest short interest is 1.30 million, so 12.47% of the outstanding shares have been sold short.

Short Interest 1.30M
Short Previous Month 1.05M
Short % of Shares Out 12.47%
Short % of Float 15.37%
Short Ratio (days to cover) 9.98

Income Statement

In the last 12 months, Medifast had revenue of $299.57 million and -$40.85 million in losses. Loss per share was -$3.69.

Revenue299.57M
Gross Profit 207.33M
Operating Income -34.78M
Pretax Income -29.15M
Net Income -40.85M
EBITDA -22.03M
EBIT -34.78M
Loss Per Share -$3.69
Full Income Statement

Balance Sheet

The company has $172.53 million in cash and $20.69 million in debt, with a net cash position of $151.85 million or $14.59 per share.

Cash & Cash Equivalents 172.53M
Total Debt 20.69M
Net Cash 151.85M
Net Cash Per Share $14.59
Equity (Book Value) 180.28M
Book Value Per Share 17.33
Working Capital 160.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$26,000 and capital expenditures -$3.84 million, giving a free cash flow of -$3.87 million.

Operating Cash Flow -26,000
Capital Expenditures -3.84M
Depreciation & Amortization 12.76M
Net Borrowing n/a
Free Cash Flow -3.87M
FCF Per Share -$0.37
Full Cash Flow Statement

Margins

Gross margin is 69.21%, with operating and profit margins of -11.61% and -13.64%.

Gross Margin 69.21%
Operating Margin -11.61%
Pretax Margin -9.73%
Profit Margin -13.64%
EBITDA Margin -7.35%
EBIT Margin -11.61%
FCF Margin n/a

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -0.94%
Shareholder Yield -0.94%
Earnings Yield -31.41%
FCF Yield -3.16%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Medifast has an Altman Z-Score of 3.55 and a Piotroski F-Score of 2.

Altman Z-Score 3.55
Piotroski F-Score 2